https://www.selleckchem.com/products/euk-134.html
om studies of only low to moderate quality. To observe the effect of topical application of recombinant human basic fibroblast growth factor (bFGF) in patients with nasal vestibulitis. One hundred patients with nasal vestibulitis were randomly divided into two groups. Local application of bFGF + conventional medication was administered in the treatment group, while conventional medication was conducted in the control group. The healing of the nasal vestibular mucosa was observed. The mucosal healing time was 18.3±4.8days in the treatmen
Like
Comment
Share
